Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Manju Sengar and Christopher Booth on essential cancer drugs

Manju Sengar and Christopher Booth on essential cancer drugs

FromThe Lancet Oncology in conversation with


Manju Sengar and Christopher Booth on essential cancer drugs

FromThe Lancet Oncology in conversation with

ratings:
Length:
12 minutes
Released:
Sep 27, 2021
Format:
Podcast episode

Description

Manju Sengar  (Tata Memorial Centre, India) and Christopher Booth (Queen’s University Cancer Research Institute, Canada) discuss their Article on the comparison between cancer drugs deemed essential by oncologists and those included in the WHO Essential Medicines List. Read the full paper:https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00463-0/fulltextContinue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Sep 27, 2021
Format:
Podcast episode

Titles in the series (100)

Editors of The Lancet Oncology and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.